Mankind Pharma Limited has submitted a regulatory disclosure to BSE Limited and National Stock Exchange of India Limited regarding its participation in an investor conference. The filing is made pursuant to Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The company's management and officials will participate in IIFL's Invest India Conference & Capital Day 2026 in London on June 23, 2026 and June 24, 2026. The meeting types will include both one-on-one and group meetings.
The company explicitly states that no unpublished price sensitive information will be shared during the aforesaid investor conference. The schedule is subject to change due to exigencies on either side.
This intimation of participation has also been uploaded on the company's website at www.mankindpharma.com.
The disclosure was signed by Hitesh Kumar Jain, Company Secretary & Compliance Officer of Mankind Pharma Limited, on June 15, 2026 at 15:28:30 IST.